Vimarsana
Biggest News Aggregation in the World

Strides Pharma Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Strides Pharma Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Strides Pharma Sciences Today - Breaking & Trending Today

JSA adds 2 more partners as Bengaluru market stays hot - Vimarsana News

JSA adds 2 more partners as Bengaluru market stays hot

Indian law firm J. Sagar Associates has continued its aggressive expansion with the addition of real estate partner Brijita Prakash and corporate partner Santosh Vijay in Bengaluru, making it six partner hires in just over a month for the firm.

Strides Pharma Science shares worth Rs 69 crore exchange hands; stock falls over 1.5% - Vimarsana News

Strides Pharma Science shares worth Rs 69 crore exchange hands; stock falls over 1.5%

13.75 lakh shares of Strides Pharma Sciences changed hands, following which, the stock price sank over 1.5 percent

Hold Strides Pharma Sciences; target of Rs 491: Sharekhan - Vimarsana News

Hold Strides Pharma Sciences; target of Rs 491: Sharekhan

Sharekhan recommended Hold rating on Strides Pharma Sciences with a target price of Rs 491 in its research report dated August 02, 2023.

Buy Strides Pharma Sciences; target of Rs 450: Sharekhan - Vimarsana News

Buy Strides Pharma Sciences; target of Rs 450: Sharekhan

Sharekhan is bullish on Strides Pharma Sciences Ltd has recommended buy rating on the stock with a target price of Rs 450 in its research report dated June 01, 2023.

Strides, TLC partner to launch liposomal amphotericin B in India - Vimarsana News

Strides, TLC partner to launch liposomal amphotericin B in India

Read more about Strides, TLC partner to launch liposomal amphotericin B in India on Business Standard. The drug maker on Thursday announced that announced that the Central Drugs Standard Control Organization (CDSCO) of India has approved TLC's New Drug Application (NDA) of Amphotericin B Liposome for injection 50 mg.